Cancer care just hit a $2B valuation. No hospital built it. A startup built on virtual navigation did. 🎯 Thyme Care raised $125 million in a Series E round this week, pushing its valuation above $2 billion, according to CNBC. That valuation roughly doubled from its Series D less than a year ago. Let that sink in for a second. The round was led by Morgan Health, with participation from Humana, CVS Health Ventures, AlleyCorp, HealthQuest Capital, and a16z Bio + Health. That is not a list of tourist investors. That is a signal. 🔹 $125M raised in Series E 🔹 Valuation now above $2 billion 🔹 Services available to more than 10.5 million people across all 50 U.S. states ...

55% of NSCLC patients can still recur after curative-intent treatment. 🎯 That number should stop every radiologist and oncologist cold when they see a new nodule in a survivor. According to BioSpace, published studies report recurrence rates of approximately 20% to 55% for non-small cell lung cancer, depending on stage, treatment and other factors. And the National Cancer Institute estimates 230,000 new lung cancer diagnoses in 2026 alone, added to the more than 680,000 Americans already living with a prior lung cancer diagnosis as of January 1, 2025. That is a massive and growing surveillance burden. And most teams do not have a clean protocol for the hardest question: when a new nodule appears on post-treatment imaging, what does it ...

I read the new CMS data on FQHCs. The numbers surprised me. 🔍 Everyone told me the One Big Beautiful Bill would hollow out the safety net. The National Association of Community Health Centers warned that many community health centers were already making tough decisions about cutting back services, reducing essential staff, and closing sites. House Minority Leader Hakeem Jeffries said hospitals and community-based health centers were closing all throughout America. The data says something different. According to the Paragon Health Institute, drawing from comprehensive CMS enrollment data, here is what actually happened between July 1, 2025 and July 17, 2026: 🔹 The number of FQHCs increased by 338, a 3.1 percent gain 🔹 The number of Rural Health Clinics ...

Are you ready for the bill your Medicare patients are about to get? 💊 Because it just got more expensive to be on Medicare. The Trump administration announced it will end the Part D Premium Stabilization Demonstration after the 2026 plan year, one year earlier than originally planned. That program was the reason drug premiums stayed manageable for the past two years. Without it, according to Elder Law Answers, the national base beneficiary premium is projected to rise about 6 percent, from $38.99 per month in 2026 to $41.33 per month in 2027. Sounds small. But let me put this in context. Here is what is actually happening: 🔹 Roughly 56 million people are enrolled in Medicare Part D drug ...

A stool test mailed to your home. That is the intervention. No clinic visit. No prep. No procedure. Just a kit in the mailbox and the choice to use it. New research published in JAMA Network Open this week put hard numbers on exactly how much that choice matters, and the data stopped me cold. Researchers from the Karolinska Institutet in Stockholm tracked 376,511 people over a 13-year study period. They compared people invited to colorectal cancer screening to those who were not. Then they looked at who actually participated. Here is what they found, according to Clinical Briefing Report: - Being invited to screening: 26% lower colorectal cancer mortality - Actually participating in screening: 43% lower colorectal cancer mortality ...

$250 million just landed in ambient AI clinical documentation. 🔥 That is what Ambience Healthcare raised in a Series D announced August 19, and it is the largest disclosed healthcare AI round of the week. According to TechQuire Post, Oak HC/FT led the round, with Andreessen Horowitz, OpenAI Startup Fund, and Optum Ventures all joining in. Let that investor table sit with you for a second. 🏥 You have a health system operator in Optum Ventures, one of the most influential AI funds in the world in the OpenAI Startup Fund, and two of the sharpest growth-stage firms on the planet in Oak HC/FT and a16z. That is not a bet on a product. That is a bet on a ...

89 experts. 96 statements. Here is what they actually agreed on. 🧠 A modified Delphi process brought 89 thoracic oncology experts together for a 3-day in-person meeting in Barcelona last September. They rated 96 clinical statements on non-metastatic NSCLC. According to the Journal of Thoracic Oncology, consensus was achieved for 62 of those statements, 31 remained without consensus, and 3 were rejected outright. That means 1 in 3 statements could not reach agreement among the world's leading thoracic oncology minds. This is the most honest document in thoracic oncology right now. Not a guidelines memo. A real snapshot of where the field stands. Here is what the consensus actually said, by domain. 📋 THE NSCLC CONSENSUS CHECKLIST: AGREED vs. CONTESTED ...

FQHC CEO: Are you celebrating the $102M HRSA award or reading the fine print? 🧾 Because the fine print is where your next two years live. On August 13, HHS announced $102 million in New Access Points awards through HRSA's Bureau of Primary Health Care. According to Granted Research, the awards go to 158 health centers to establish more than 415 new service delivery sites, expanding comprehensive primary care to nearly 1 million people. HHS called it the first major expansion of the Health Center Program since 2019. Secretary Kennedy called it the biggest investment in the program in two to three decades. That framing is real. And it deserves a reality check. 📐 Do the arithmetic. $102 million across ...

Radiologist, do you know what happens when your AI is wrong? 🎯 Not wrong in a lab. Wrong on a real patient, in your department, on a Tuesday afternoon. Most people in this space cannot answer that question with confidence. And as of August 25, 2026, ECRI decided that gap is no longer acceptable. ECRI, the nonprofit patient-safety organization that has run its Problem Reporting Network since 1972, just expanded that network specifically to capture errors, malfunctions, and near misses involving AI tools in patient care, including diagnostic imaging. It is cross-vendor by design. Any provider can report on any AI tool, whether or not the vendor opted in. Here is what the data behind that decision looks like. ECRI ...